Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 29 · 2 feeds behind: Congress trades, 13 days, and 1 more · Every feed →

All 18,993Congress 9,936Executive branch 203Insiders 8,854
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

buys only · 18,993 trades

Trades
18,993
Buys 18,993 · Sells 0
People
2,515
Stocks
2,581
Disclosed value
$11.8B
range midpoints · Congress & executive
Filed late
2,846
  1. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$8Kdisclosed Jul 29 · filed the same day
  2. ▲ BUYOrbimed Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  3. ▲ BUYSnehal Patel CEO and CFOGLSI Greenwich LifeSciences, Inc.$20.4Kdisclosed Jul 29 · filed 2 days after the trade 2 rules fired
  4. ▲ BUYAH Equity Partners Bio III, L.L.C. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  5. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$9.1Kdisclosed Jul 29 · filed the same day
  6. ▲ BUYPeter Altman President and CEOBCDA BioCardia, Inc.$3.9Kdisclosed Jul 29 · filed the same day
  7. ▲ BUYCarl L Gordon DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  8. ▲ BUYMarc L Andreessen 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  9. ▲ BUYFaisal Ghiath Sukhtian DirectorOTLK Outlook Therapeutics, Inc.$100Kdisclosed Jul 29 · filed the same day
  10. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$31.7Kdisclosed Jul 29 · filed 1 day after the trade
  11. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$255Kdisclosed Jul 28 · filed 1 day after the trade
  12. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$1.3Mdisclosed Jul 28 · filed 4 days after the trade
  13. ▲ BUYAvoro Capital Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade
  14. ▲ BUYCurtland E Fields DirectorKRNY Kearny Financial Corp.$3.4Kdisclosed Jul 28 · filed 1 day after the trade
  15. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$1.8Mdisclosed Jul 28 · filed 4 days after the trade
  16. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  17. ▲ BUYAvoro Ventures LLC DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade
  18. ▲ BUYAmit Kumar Chief Executive OfficerANIX Anixa Biosciences Inc$17.2Kdisclosed Jul 28 · filed 1 day after the trade
  19. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  20. ▲ BUYErez Meltzer Chief Executive OfficerNNOX Nano-X Imaging Ltd.$33.5Kdisclosed Jul 28 · filed 1 day after the trade
  21. ▲ BUYHrt Financial LP 10% ownerZNB Zeta Network Group$22.7Kdisclosed Jul 28 · filed 1 day after the trade
  22. ▲ BUYAvoro Capital Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$144Kdisclosed Jul 28 · filed the same day
  23. ▲ BUYMerrill Lynch, Pierce, Fenner & Smith Inc. 10% ownerNMZ Nuveen Municipal High Income Opportunity Fund$92disclosed Jul 28 · filed 4 days after the trade
  24. ▲ BUYHorizon Kinetics Asset Management LLC 10% ownerTPL Texas Pacific Land Corp$409disclosed Jul 28 · filed 1 day after the trade
  25. ▲ BUYBehzad Aghazadeh DirectorSCTX Scribe Therapeutics, Inc.$35Mdisclosed Jul 28 · filed 4 days after the trade